Bone Marrow Transplant (Stem Cell Transplant)

Harold C. Simmons Comprehensive Cancer Center

Appointment New Patient Appointment or 214-645-4673

National Comprehensive Cancer Center (NCI) logo

Recognized as one of the leading programs of its kind, UT Southwestern's hematologic malignancies team has performed approximately 2,500 bone marrow transplants (also known as stem cell transplants) while achieving some of the strongest survival rates for patients in the region.

Our highly specialized program is part of the Harold C. Simmons Comprehensive Cancer Center, the only National Cancer Institute-designated comprehensive cancer center in North Texas.

What Is a Bone Marrow Transplant (BMT)?

A bone marrow transplant (BMT) is a procedure that replaces unhealthy bone marrow – the tissue inside bones that produces blood-forming cells – with healthy bone marrow stem cells that should restore normal blood cell production.

Bone marrow stem cells are early cells that develop into red blood cells, white blood cells, and platelets. These cells are essential for carrying oxygen, fighting infection, and preventing bleeding. When bone marrow is damaged by disease or treatment, the body cannot make enough healthy blood cells.

A BMT may be used to treat conditions such as blood cancers, bone marrow failure disorders, and certain inherited or acquired immune system conditions.

In some cases, BMT allows doctors to safely use high-dose chemotherapy or radiation. These treatments can destroy cancer cells but also damage bone marrow. The transplant helps restore blood and immune cell production afterward.

Donor stem cells may come from a matched family member, an unrelated donor, or donated umbilical cord blood. In addition to replacing bone marrow, donor cells can also provide an immune response that helps attack remaining cancer cells.

Why Choose UT Southwestern for a Bone Marrow Transplant?

Established in 1998, UT Southwestern’s Bone Marrow Transplant Program is among the most experienced in the region. For patients and families, this means proven stem cell treatment protocols, stable care teams, and well-coordinated treatment pathways.

Our program is accredited by the Foundation for the Accreditation of Cellular Therapy, which recognizes top-quality patient care. We have also been deemed a national center of excellence by all major national health insurance carriers.

Our experienced physicians, nurses, and other care providers guide patients through every step of the bone marrow transplant process. We strive to deliver the most appropriate and effective care possible, and we’re here to manage care from diagnosis to personalized treatment and beyond. UT Southwestern Medical Center’s Bone Marrow Transplant Program has the highest one-year survival rate in North Texas.

BMT (Stem Cell) Research Lab

What Diseases Can BMT Treat?

BMTs are used to treat a wide range of conditions that affect the blood, bone marrow, and immune system. In some cases, a transplant is part of cancer treatment. In others, it replaces bone marrow that no longer works properly due to disease or genetic conditions.

BMT may be used to treat blood cancers, including:

Bone marrow transplant can also treat noncancerous blood and immune conditions, such as:

In select cases, BMT may be used for rare genetic or metabolic disorders that damage bone marrow or prevent the body from making healthy blood cells. A transplant can replace defective marrow with healthy, functioning stem cells.

Not every condition is treated the same way, and transplant may not be appropriate for everyone. Doctors carefully evaluate each patient’s diagnosis, overall health, and treatment goals to determine whether a bone marrow transplant is the right option.

What Are the Types of Bone Marrow Transplants?

There are two main types of bone marrow transplants: autologous, which use the patient’s own stem cells, and allogeneic, which rely on stem cells from a donor. Doctors consider several factors to determine the best transplant option for each patient.

Autologous Stem Cell Transplants

A person might receive an autologous transplant if their cancer is particularly sensitive to high-dose chemotherapy or radiation or if no suitable donor is available. It’s often chosen for conditions such as lymphoma and multiple myeloma, and it can be a good option for older patients who might not tolerate the risks associated with donor transplants.

With autologous transplants:

  • Patients use their own stem cells, so there’s no need to find a match
  • There's almost no chance of graft-versus-host disease, where the transplanted cells attack the recipient's tissues
  • Immune function often returns more quickly, reducing the risk of severe infections
  • Serious complications are less common, allowing some patients to handle treatment better

Risks of Autologous Stem Cell Transplants

Autologous transplants pose a risk of reintroducing cancer cells if the harvested stem cells contain traces of the disease. They also don't provide the extra immune boost from donor cells that can attack any remaining cancer. As a result, relapse rates can be higher than with allogeneic transplants.

Allogeneic Stem Cell Transplants

A person might receive an allogeneic transplant when their cancer (often leukemia or myelodysplastic syndrome) requires not only high-dose chemotherapy but also the donor’s immune cells to help destroy lingering cancer. Common donor sources include a matched sibling, an unrelated volunteer found through a registry, or umbilical cord blood.

With allogeneic transplants:

  • Donor immune cells can actively fight any remaining cancer cells, called the graft-versus-cancer effect
  • Certain leukemias and related disorders have better long-term control because of this immune response
  • There’s less chance of reintroducing cancer back into the body
  • Related, unrelated, and cord blood donors offer multiple avenues to find a suitable match

Risks of Allogeneic Stem Cell Transplants

Allogeneic transplants carry higher risks than autologous transplants, including graft-versus-host disease (GVHD). Immune recovery can be slower, increasing the risk of severe infections. Treatment-related mortality is also higher, reflecting the complexity of matching, transplant procedures, and long-term care.

To help manage chronic GVHD, UT Southwestern’s Chronic GVHD Program provides coordinated, multidisciplinary care to support quality of life.

transplant patient consulting with a doctor

What Should Patients Expect with a Bone Marrow Transplant?

Before the Bone Marrow Transplant

Care begins with a consultation and pretransplant workup. Patients meet their transplant physician and nurse, review medical history, and complete tests to ensure that they are healthy enough for transplant. They’ll also meet with a transplant coordinator and a social worker, who can help answer questions and prepare them for what’s ahead.

Some patients may be admitted to William P. Clements Jr. University Hospital before the transplant, while others may begin as outpatients based on their medical needs.

Patients may need one or more tests, such as:

  • Bloodwork and imaging studies
  • Heart and lung function tests
  • Kidney and liver evaluations
  • Bone marrow biopsy
  • Dental evaluation to prevent infections
  • Fertility preservation consultation, if appropriate

As part of the preparation, the care team will place a long, thin tube (called a central line) into a large vein in the patient’s chest or neck. This catheter stays in place throughout treatment and allows the team to safely infuse stem cells, medications, and blood products.

Stem Cell Collection

The collection process depends on the type of transplant:

  • Autologous transplant: The patient gets injections of growth factors to stimulate stem cell production. The care team will collect the cells from the patient’s blood using a process called apheresis, then freeze and store them until transplant day.
  • Allogeneic transplant: The donor typically undergoes a similar apheresis process. In some cases, doctors will collect bone marrow cells surgically from the donor’s pelvic bone.
Cancer patient receiving chemotherapy

During the Bone Marrow Transplant

Conditioning

Once testing and stem cell collection are complete, the patient begins the conditioning process to prepare the body for transplant. Conditioning involves chemotherapy and sometimes radiation to:

  • Destroy cancer cells, if receiving treatment for cancer that could spread
  • Suppress the immune system
  • Prepare the bone marrow for the new stem cells

Our care team will tailor the conditioning regimen based on the patient’s diagnosis, overall health, and the type of transplant they’ll receive. Most patients receive chemotherapy before a bone marrow transplant as part of conditioning. Some receive high-dose chemotherapy, while others may get lower doses or different medications (reduced-intensity conditioning).

Transplant Day (Day 0)

The bone marrow transplant takes place after completion of the conditioning process. This milestone day is called "Day 0" because it marks the beginning of the recovery timeline.

The transplant infusion is painless, and the patient will be awake the entire time.

If the stem cells were frozen, the team will thaw them in a warm water bath just before the infusion. The patient receives premedications such as Tylenol® and Benadryl®. Then the care team will infuse the stem cells through the central line.

A nurse will stay with the patient throughout the procedure to monitor them, keep them comfortable, and help with any side effects, such as:

  • A tickle in the throat
  • Nausea or queasiness
  • Chills or shivering
  • A taste or smell caused by the preservative (DMSO) in frozen cells

After the Bone Marrow Transplant

In the days after transplant, blood cell counts will temporarily drop before the new cells begin to grow. During this time, the patient may be at increased risk for infection, anemia, or bleeding. Our care team will closely monitor the patient and may give medications, blood transfusions, or growth factors to help blood cell counts recover.

The new stem cells make their way to the bone marrow, where they begin to produce healthy blood cells. Most patients start to see their counts recover within 10 to 20 days.

Most patients stay in the hospital for three to four weeks after transplant, depending on how they’re doing. After discharge, they return to our clinic two to three times a week during the first 100 days. Full recovery can take several months to a year, and our transplant team will continue to support them every step of the way.

Full immune recovery takes time. While many patients resume daily activities within several months, complete recovery can take up to a year or longer, especially after donor transplants.

Bone marrow transplant outcomes vary widely. Success depends on factors such as the disease being treated, transplant type, donor match, patient age, and overall health. For some conditions, transplant can lead to long-term remission or cure. For others, it may extend survival or improve quality of life. Ongoing follow-up care is essential to monitor for complications and support long-term health.

What Specialized Services for Bone Marrow Transplants Does UT Southwestern Offer?

Our unique approach to bone marrow (stem cell) transplant care includes:

  • Engineered immune cell therapy (CAR T-cell therapy): For some blood cancers, UT Southwestern uses immune cells that are engineered with gene therapy to better recognize and attack cancer cells. This option can provide new hope for patients when standard treatments are not effective.
  • Specially trained team: Our physicians, nurses, coordinators, pharmacists, and support staff have deep experience caring for patients with blood cancers and other blood disorders.
  • Advanced technology for donor matching: Our Histocompatibility and Immunogenetics (HLA) Laboratory uses leading-edge technology to determine the best donor match, helping improve outcomes in a way that many centers cannot match.
  • A rare option for safer radiation: Patients in our program have the option for total marrow irradiation (TMI), a highly specialized treatment that targets diseased bone marrow while protecting healthy tissue.
  • Clinical trials access: UT Southwestern researchers, including Yasin Madanat, M.D., lead groundbreaking studies that give patients early access to promising therapies for blood cancers.
  • Broad bone marrow transplant experience: We have expertise in both autologous and allogeneic transplants and offer outpatient options for autologous procedures.
  • Support services: Rehabilitation services, integrative therapies, and nutrition counseling help patients and families through bone marrow transplantation, cellular therapies, and beyond.
  • Survivorship program: Led by Vivian Irizarry, M.D., our adolescent and young adult (AYA) survivorship clinic provides ongoing care and support for patients after transplant.
  • Chronic GVHD Program: Chronic graft-versus-host disease (GVHD) can affect quality of life after an allogeneic transplant. Our Chronic GVHD Program brings together specialists across multiple areas of care to help manage symptoms, reduce complications, and support long-term well-being.

At UT Southwestern, we perform bone marrow transplants and cellular therapies for patients ranging in age from early adulthood to their 70s. We also offer a dedicated pediatric bone marrow transplant program providing specialized care for younger patients.

Compassionate Care Throughout the Journey

We provide excellent, compassionate care for patients with all types of blood cancers. From a personalized patient experience to cutting-edge treatments, discover what sets us apart.

Spencer is given a 'second birthday'

When Spencer Swann fell ill with pneumonia after his 39th birthday, he found he had stage 3 multiple myeloma. With the care of his wife Anna, his support system, and his team at Simmons Cancer Center, he is now in remission. After undergoing an autologous stem cell transplant, the first outpatient transplant at our Cancer Care Outpatient Building, Spencer was given a “second birthday.” Now, Spencer is training for his second marathon.

Helping Dad beat leukemia: Jon and Chuck’s story

Chuck was the first person in the U.S. to receive a new transplant technique at Simmons Cancer Center to treat his acute myeloid leukemia – thanks to his son Jon donating stem cells.